AUTHORS

Bret Jensen

Bret Jensen was chief investment strategist from 2008-2011 for Simplified Asset Management (S.A.M.), a small long/short hedge fund based in Miami. The fund was in top 5% of long/short hedge funds for total return in its first full year (2009) as ranked by Hedgeco fund database (more than 450 funds in category). Jensen has nearly 20 years of experience in the financial services industry, including more than a decade of managerial experience at American Express. He holds a Bachelor of Science degree in finance from Arizona State University. His personal blog is at http://www.bretjenseninvests.com. Jensen acts as corporate secretary for Florida Alternative Investment Association, which encompasses more than 100 managers managing more than $30 billion in assets under management. Follow Bret on Twitter: @Bret_Jensen.

Email Bret Jensen

Recent Articles By The Author

Investing in Small Biotechs? Check Out the CFO First

Bret Jensen Aug 9, 2019 9:08 AM EDT

They're the most important executive at most small developmental or early commercialization concerns.

3 Tariff Questions That Must Wait for Answers

Bret Jensen Aug 7, 2019 8:30 AM EDT

It will take time to determine the impact of new tariffs on consumer prices, business bottom lines and the achievement of a trade deal with China.

Big Pharma Sees Pockets of Recent Insider Buying

Bret Jensen Aug 5, 2019 8:35 AM EDT

AbbVie and Bristol-Myers Squibb are two pharmaceutical giants where insiders have snatched up big blocks of stock.

Swinging for the Small-Cap Biotech Fences Requires Accepting Strikeouts

Bret Jensen Aug 2, 2019 8:53 AM EDT

Striking out is painful, but is not as impactful as missing out on the next potential home run because you're still brooding about whiffing on your last investment.

3 Watch Items for the Market That Don't Involve the Fed or Brexit

Bret Jensen Jul 31, 2019 9:30 AM EDT

The trio to keep an eye on are U.S.-China trade talks, business investment and political rhetoric.

2 Promising $5 Biotech Stocks to Consider on Recent News

Bret Jensen Jul 29, 2019 10:00 AM EDT

Jounce Therapeutics and Ocular Therapeutix each provided investors with positive news morsels last week.

3 Trends Driving This Earnings Season

Bret Jensen Jul 26, 2019 8:30 AM EDT

With a third of S&P 500 stocks having reported, these 3 trends are coming to the fore.

Amazon Will Set the Tone for Friday

Bret Jensen Jul 25, 2019 4:06 PM EDT

Fairly quiet day in the market. All the major indices end the day sporting losses of a half to one percent. Lots of Q2 reports crossing the wires today. Tesla , as noted earlier, falls over 10% on results and was a factor in the Nasdaq being the wea...

What Will the Fed Feed Us?

Bret Jensen Jul 25, 2019 2:13 PM EDT

The market has fell some across the board since our last update. Been a pretty quiet day, and the decline has been orderly from all-time highs reached yesterday. Q2 earnings reports continue to hit the wires in a fast and furious manner, as they wil...

High Flyers and Low Flyers

Bret Jensen Jul 25, 2019 12:11 PM EDT

Equities are a bit higher across the board since our last update. Homebuilders continue to be in the green as 30-year mortgage rates hover near three-year lows. This is starting to have an effect as purchase application demand has posted its biggest...

Email

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.